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Salmonella strains cause three main types of diseases in people: gastroenteritis, enteric
(typhoid) fever, and non-typhoid extra-intestinal disease with bacteremia. Genetic analy-
sis indicates that each clinical syndrome requires distinct sets of virulence genes, and
Salmonella isolates differ in their constellation of virulence traits. The spv locus is strongly
associated with strains that cause non-typhoid bacteremia, but are not present in typhoid
strains.The spv region contains three genes required for the virulence phenotype in mice:
the positive transcriptional regulator spvR and two structural genes spvB and spvC. SpvB
and SpvC are translocated into the host cell by the Salmonella pathogenicity island-2 type-
three secretion system. SpvB prevents actin polymerization by ADP-ribosylation of actin
monomers, while SpvC has phosphothreonine lyase activity and has been shown to inhibit
MAP kinase signaling. The exact mechanisms by which SpvB and SpvC act in concert
to enhance virulence are still unclear. SpvB exhibits a cytotoxic effect on host cells and is
required for delayed cell death by apoptosis following intracellular infection. Strains isolated
from systemic infections of immune compromised patients, particularly HIV patients, usu-
ally carry the spv locus, strongly suggesting that CD4T cells are required to control disease
due to Salmonella that are spv positive. This association is not seen with typhoid fever,
indicating that the pathogenesis and immunology of typhoid have fundamental differences
from the syndrome of non-typhoid bacteremia.
Keywords: Salmonella, spv, virulence, non-typhoid bacteremia, apoptosis, ADP-ribosylation, phosphothreonine
lyase, CD4
Salmonella enterica strains are facultative intracellular pathogens
that can produce both localized and disseminated, systemic disease
in humans and a variety of other vertebrates (Guiney et al., 1994,
1995; Fierer and Guiney, 2001; Coburn et al., 2007). Non-typhoid
Salmonella strains are endemic in domestic agricultural animal
populations throughout the world, and provide a huge reservoir
for human infection. An extensive body of work has shown that
all S. enterica strains share common, core features of pathogenesis.
This analysis has also shown that the ability to produce the distinc-
tive clinical syndromes of typhoid fever, enteritis, or non-typhoid
disseminated infection is due to the presence of speciﬁc sets of
genes that are frequently located in pathogenicity islands and on
phage or virulence plasmids (Fierer and Guiney, 2001).
SALMONELLA TYPE III PROTEIN SECRETION SYSTEMS IN
PATHOGENESIS
Common features of Salmonella pathogenesis include the abil-
ity to induce intestinal epithelial cells to take up the organism
into a Salmonella-containing vacuole (SCV), and the ability to
manipulate the intracellular trafﬁcking of the vacuole to promote
survival and replication of the pathogen. These core virulence
processes depend on the function of two distinct type-three secre-
tion systems (abbreviated TTSS or T3SS) that transfer multiple
effector proteins into the host cell cytoplasm. Following inges-
tion, Salmonella attach to intestinal epithelial cells and induce
uptake of the bacteria into specialized membrane-bound vesicles
termed SCV (reviewed in Galan, 2001; Ly and Casanova, 2007).
This invasion process requires the TTSS encoded in the Salmonella
pathogenicity island-1 (SPI-1) locus. The SPI-1 TTSS transfers a
number of effector proteins into host epithelial cells, acting on
Rho family GTPases and actin to produce physiological and struc-
tural changes in the cytoskeleton leading to bacterial uptake. The
Rho family GTPases lead to activation of pro-inﬂammatory sig-
naling pathways involving MAP kinases and NF-κB. Inside the
SCV, Salmonella strains express a second TTSS encoded by the
SPI-2 locus (Knodler and Steele-Mortimer, 2003; Waterman and
Holden, 2003; Abrahams and Hensel, 2006). A variety of SPI-
2 effectors regulate the trafﬁcking of the SCV and interactions
with the endosomal vesicular sorting process. These effectors posi-
tion the SCV in a perinuclear position closely associated with the
Golgi apparatus (Abrahams et al., 2006; Deiwick et al., 2006),
stimulate the accumulation of actin ﬁlaments around the SCV
(Poh et al., 2007), and also induce the formation of long, ﬁl-
amentous vesicular structures called Sifs (Brumell et al., 2002).
Salmonella are able to replicate inside intestinal epithelial cells and
induce apoptosis after 18–24 h (Kim et al., 1998; Paesold et al.,
2002). In polarized intestinal monolayers, Salmonella can also
pass through the epithelial cells and exit on the basolateral side
before monolayer disruption occurs. Mucosal macrophages ingest
Salmonella, but a massive inﬂux of neutrophils quickly ensues in
animals that develop clinical enteritis. Salmonella can also pass
through the intestinal mucosa and disseminate by an SPI-1 inde-
pendent process requiring CD18 positive cells (Vazquez-Torres
et al., 1999).
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The SPI-2 TTSS and a subset of effectors have been shown
to be required to produce systemic disease (Knodler and Steele-
Mortimer, 2003; Waterman and Holden, 2003; Abrahams and
Hensel, 2006). A large body of experimental evidence indicates
that extra-intestinal Salmonella infection occurs inside tissue
macrophages (Fields et al., 1986;Vassiloyanakopoulos et al., 1998).
Both clinical experience in humans and experimental studies in
mice indicate that extracellular antibiotics such as the aminogly-
cosides are not effective against systemic Salmonella infections,
demonstrating that Salmonella can grow within cells and spread
from cell-to-cell without signiﬁcant exposure to the extracellular
space (Fierer et al., 1990; Vassiloyanakopoulos et al., 1998). SPI-
2 TTSS effectors appear to act to promote intracellular infection
by increasing the ability to Salmonella to resist the antimicro-
bial activity of macrophages and to grow within the cells. In
macrophages, Salmonella appear to inhibit the recruitment of the
NADPH oxidase to the phagosome, and this inhibition requires
the SPI-2 TTSS function (Vazquez-Torres et al., 2000; Gallois et al.,
2001). In support of the interaction between the SPI-2 virulence
system and oxidative killing, gp91 phox−/− knockout mice lack-
ing oxidase activity are fully susceptible to infection with SPI-2
mutants, while SPI-2 mutants are severely attenuated in mice with
an intact NADPH oxidase (Vazquez-Torres et al., 2000). Unfortu-
nately, the speciﬁc SPI-2 effectors involved in downregulating the
NADPH oxidase have not been identiﬁed.
THE spv VIRULENCE LOCUS IN SALMONELLA
Non-typhoid Salmonella strains associated with extra-intestinal
infections in humans and animals carry an additional locus termed
spv (Guiney et al., 1994, 1995; Fierer and Guiney, 2001). The spv
genes are located within a highly homologous region contained on
virulence plasmids found in the subspecies 1 lineage of S. enterica,
and were named for the designation Salmonella plasmid virulence
(Figure 1). The spv locus enhances mouse virulence by several
orders of magnitude in LD50, depending on the Salmonella serovar
and the mouse strain. The virulence phenotype is seen in both
ItyS and ItyR mice, also referred to as Nramp1 (Slc11a1) mutant
and wild-type mice respectively. Furthermore the spv effect has
also been documented experimentally in calves and pigs and by
molecular epidemiology in humans (Fierer et al., 1992; Libby
et al., 1997). Subsequent work showed that the spv genes are
located in the chromosome in certain other S. enterica lineages
(Boyd and Hartl, 1998; Libby et al., 2002). spv-carrying serovars
associated with human disease include Typhimurium, Enteritidis,
Choleraesuis, Dublin, and Arizona. Certain host-adapted animal
pathogens, such as Gallinarum/Pullorum and Abortusovis, also
contain the spv locus. The plasmid spvABCD genes are arranged
in an operon positively regulated by the upstream spvR gene, as
shown in Figure 1 (Fang et al., 1991; Krause et al., 1991, 1992).
The spvD gene is missing in the chromosomal locus as found in
serovar Arizona (Libby et al., 2002). The SpvR protein is a positive
transcriptional regulator of the LysR family and binds to inverted
repeat recognition sequences upstream of its own promoter and
the spvA promoter (Krause et al., 1991, 1995; Grob and Guiney,
1996; Grob et al., 1997). Transcription initiation at both promot-
ers requires the alternative sigma factor RpoS (“stationary phase
sigma factor”; Fang et al., 1992; Chen et al., 1995). Expression
of the spv operon is induced by the intracellular environment
of host cells and is dependent on both SpvR and RpoS (Fierer
et al., 1993; Chen et al., 1996). Genetic analysis demonstrates that
the spvR and spvBC genes are required for the virulence pheno-
type of the spv locus, while mutations in spvA and spvD do not
have a reproducible virulence phenotype in mice (Roudier et al.,
1992).
Biochemical activities for SpvB and SpvC have been identiﬁed
(Lesnick et al., 2001; Li et al., 2007). As shown in Figure 1, the
SpvB protein has two distinct domains separated by a run of seven
proline residues (nine in Dublin; Guiney and Lesnick, 2005). The
N-terminal domain belongs to a large family of bacterial proteins
identiﬁed by genome sequencing. Early work found members of
FIGURE 1 | Map of the spv region found on virulence plasmids
in subspecies 1 strains, not drawn to scale.The spvR gene is
transcribed separately from the spvABCD genes. SpvR activates
transcription at both promoters in concert with the RpoS sigma factor.
The expansion shows the general structure of the SpvB protein,
with N- and C-terminal domains separated by a run of proline residues (P).
EAE denotes residues at the active site for the ADP-ribosylation
activity.
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this family in certain insect toxins from Enterobacteriaceae that
infect insects, but the regions of homology do not involve the toxin
activity (Lesnick and Guiney, 2001). At present, the functions of
this widely distributed protein family are unknown. In contrast,
the C-terminal domain of SpvB contains ADP-ribosyltransferase
activity that covalently modiﬁes G-actin monomers and prevents
their polymerization into F-actin ﬁlaments (Lesnick et al., 2001;
Hochmann et al., 2006). Since F-actin is continuously formed
and depolymerized in the cell, the activity of SpvB in the host
cell cytoplasm leads to loss of the F-actin cytoskeleton (Lesnick
et al., 2001; Browne et al., 2002). The C-terminal domain is both
necessary and sufﬁcient to depolymerize cellular F-actin, and the
N-terminal domain is not required (Lesnick et al., 2001). A site-
speciﬁc mutation at the active site (see Figure 1) was used to
show that the actin ADP-ribosylating activity of SpvB is required
for the virulence phenotype in mice and for actin depolymer-
ization in infected macrophages (Lesnick et al., 2001). SpvB is
required for Salmonella proliferation in a subset of monocyte-
derived human macrophages, and is required for the late apoptosis
seen in host cells during Salmonella infection (Libby et al., 2000;
Paesold et al., 2002). Puriﬁed, enzymatically active SpvB pro-
tein does not enter intact eukaryotic cells (Lesnick et al., 2001).
Instead, SpvB is translocated from Salmonella in the SCV into
the host cell cytoplasm by a process dependent on SPI-2 (Browne
et al., 2002, 2008). Recently, SpvC and the related Shigella effec-
tor OspF have been shown to have phosphothreoninelyase activity
that irreversibly inactivates host cell MAP kinases by removal of
phosphate and modiﬁcation of the target threonine (Li et al.,
2007). The role of this activity in the virulence phenotype of SpvC
has yet to be determined. SpvC is also translocated by the SPI-2
TTSS (Mazurkiewicz et al., 2008). Although SpvB and SpvC have
distinct and seemingly unrelated biochemical actions, both are
required to produce the spv virulence phenotype (Roudier et al.,
1992). Cloned spvB can complement a non-polar spvB mutant,
but spvB without spvC does not have a detectable virulence phe-
notype (Guiney and Fierer, unpublished). These results strongly
suggest that SpvB and SpvC act at different stages to affect a com-
mon pathway or process in the host cell required for resistance
to infection.
HOST CELL DEATH INDUCED BY SALMONELLA
Salmonella strains produce host cell death during infection of cell
cultures by several different mechanisms. Salmonella grown under
conditions to express the SPI-1 TTSS activate the NLRC4 inﬂam-
masome in macrophages by a mechanism that depends on the
SPI-1 TTSS rod component PrgJ and ﬂagellin subunits (Franchi
et al., 2006; Miao et al., 2006, 2010). The inﬂammasome activates
caspase-1 leading to processing and release of IL-1β and IL-18,
and cell death by a process termed pyroptosis (Fink and Cook-
son, 2007). The macrophages lyse, and bacteria are released to
the extracellular space. The signiﬁcance of this process for Salmo-
nella pathogenesis is unknown. Recent studies show that caspase-1
apparently has a protective role for the host during systemic Salmo-
nella infection, suggesting that caspase-1 activation by Salmonella
would be detrimental to the organism in disseminated disease
(Lara-Tejero et al., 2006; Raupach et al., 2006). However, these
studies do not distinguish the roles of caspase-1 in the release
of cytokines versus the induction of pyroptosis. Furthermore,
SPI-1 TTSS mutants (including SipB mutants) have normal viru-
lence for systemic disease in mice, indicating that SipB-mediated
macrophage pyroptosis may not have a signiﬁcant role in systemic
infection (Guiney, 2005). The SPI-2 TTSS, which is essential for
systemic virulence, does not appear to translocate ﬂagellin nor
activate the inﬂammasome (Miao et al., 2010). In contrast, human
intestinal epithelial cells do not undergo pyroptosis even though
Salmonella invasion involves the SPI-1 TTSS and SipB (Kim et al.,
1998; Paesold et al., 2002). Instead, Salmonella strains proliferate
inside epithelial cells and induce delayed cell death (16–24 h after
infection) by a process that depends on both the SPI-2 TTSS and
the spv locus (Paesold et al., 2002). Salmonella-induced epithelial
cell death has features of classical apoptosis including cell surface
exposure of phosphatidylserine, mitochondrial membrane depo-
larization, caspase-3 activation, cytokeritin-3 cleavage, and DNA
fragmentation between nucleosomes (Kim et al., 1998; Paesold
et al., 2002). A similar process occurs in macrophages infected
with Salmonella that are grown under conditions that do not
induce SPI-1 expression, or when SPI-1 mutants are used (Libby
et al., 2000; Browne et al., 2002; Hsu et al., 2004). An impor-
tant role for this delayed process of macrophage apoptosis during
systemic Salmonella infection in vivo is supported by (1) histo-
logic evidence of apoptosis in livermacrophages (Richter-Dahlfors
et al., 1997), and (2) correspondence between the bacterial factors
(such as SpvB) required for apoptosis in cell culture and for vir-
ulence in vivo (Libby et al., 2000; Browne et al., 2002; Hsu et al.,
2004).
Regulation of apoptosis in macrophages is complex, with com-
peting pathways leading to pro- and anti-apoptotic factors that
govern the ultimate outcome. In general, primary macrophages
exposed to bacterial products and/or pro-inﬂammatory, death-
inducing cytokines such as TNF become activated rather than
undergo apoptosis, due to the induction of factors that favor cell
survival (Park et al., 2002; Hsu et al., 2004). Clearly, macrophages
have to survive at sites of infection in order to function as immune
effector cells. However, certain bacterial pathogens have evolved
speciﬁc virulence mechanisms that block the pro-survival path-
ways of macrophages, tipping the balance of signals in favor of
apoptosis and resulting in the death of the macrophage. Figure 2
shows a schematic representation of the key pathways leading
to the induction of apoptosis during infection of macrophages
with Salmonella. For clarity, many factors and co-factors in the
individual pathways are not shown. The data in support for this
scheme were obtained primarily through the use of macrophages
from speciﬁc knockout and transgenic mice in combination with
speciﬁc bacterial mutants. As seen in Figure 2, apoptosis of wild-
type macrophages in this system requires the SPI-2 TTSS but
not the SPI-1 TTSS (SipB). Therefore, the process of apoptotic
cell death clearly differs from pyroptosis dependent on SipB as
described above (Fink and Cookson, 2007). Salmonella infection
triggers activation of TLR4 by LPS. Although Salmonella pro-
duces ligands for other TLRs such as TLR2, TLR5, and TLR9,
TLR4 has been shown to be required for apoptosis induced by
Salmonella, so we have not shown the other TLRs in this scheme.
TLR4 ligation triggers activation of the adapter proteins MyD88
and TRIF (also known as lps2). As seen in Figure 2, the TRIF
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FIGURE 2 | General scheme of pathways affecting delayed apoptosis in
Salmonella-infected host cells. Roles for each of the host factors were
demonstrated using knockout mice or inhibitors. SpvB is known to be
required and presumably acts through actin depolymerization, but the exact
mechanism connecting SpvB to the induction of apoptosis remains to be
clariﬁed. Although SpvC and SseL have been shown to inhibit p38 and NF-κB
respectively, the roles of these effectors in apoptosis is hypothetical at
present.
pathway is a major activator of apoptosis, through a key inter-
mediate kinase, PKR (also known as dsRNA responsive protein
kinase because of its involvement inTLR3 signaling).Macrophages
deﬁcient in TRIF or PKR show marked reduction in Salmonella-
induced apoptosis. PKR activates interferon-response factor-3
(IRF-3) and also phosphorylates eukaryotic translation initia-
tion factor 2α (eIF2α), inhibiting protein synthesis and therefore
blocking the expression of anti-apoptotic factors. Macrophages
lacking IRF-3, and transgenic knock-in macrophages expressing
a mutant eIF2α that is not phosphorylated by PKR both show
reduced apoptosis after Salmonella infection (data in reference
Hsu et al., 2004). These results clearly establish theTRIFpathway as
a major transducer of pro-apoptotic signaling during Salmonella
infection.
Ligation of TLR4 also activates pathways dependent on the
MyD88 adapter protein, leading to activation of MAP kinases and
NF-κB. The MAP kinase isoform JNK acts with NF-κB to induce
pro-inﬂammatory, death-inducing cytokines such as TNF. How-
ever, NF-κB and the MAP kinase p38 have critical roles in the
induction of anti-apoptotic factors leading tomacrophage survival
after exposure to LPS. Macrophages treated with a p38 inhibitor,
or that have knockouts in MyD88 or IKKα undergo apoptosis after
exposure to LPS alone (Park et al., 2002;Hsu et al., 2004).However,
it is important to note that normal macrophages do not undergo
apoptosis after treatment with LPS because the anti-apoptotic
signaling dependent on p38 and NF-κB predominates.
ROLES OF SALMONELLA VIRULENCE FACTORS IN HOST CELL
APOPTOSIS
The delayed apoptosis of macrophages after Salmonella infection
requires PhoP (Valle and Guiney, 2005) and the SPI-2 TTSS, but
not SPI-1 (Hsu et al., 2004). PhoP is a master regulatory factor
that controls the expression of a large number of genes during
intracellular infection. We found that PhoP is required indepen-
dent of SPI-2 for Salmonella to induce death by a novel mecha-
nism in THP-1 human macrophage-like cells (Valle and Guiney,
2005). The SPI-2 TTSS translocates effector proteins across the
membrane of the SCV into the host cell cytoplasm. Without the
intervention of speciﬁc Salmonella effector proteins, the p38 and
NF-κB anti-apoptotic pathways dominate, and cells infected with
Salmonella SPI-2 mutants do not undergo delayed apoptosis (Hsu
et al., 2004). Two major SPI-2 TTSS-secreted effectors that induce
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apoptosis have been identiﬁed: SpvB and SseL. The spv locus is
required for the induction of apoptosis in human macrophages
(Libby et al., 2000), and the ADP-ribosylating activity of SpvB
is required for caspase-3 activation during human macrophage
infection. However, the SpvB mutant does not reduce apopto-
sis to the level seen with an SPI-2 mutant that abolishes the
TTSS function. This result suggests that other SPI-2 secreted effec-
tors may also contribute to apoptosis. One of these candidates is
SseL, shown to be involved in macrophage cytotoxicity (Rytko-
nen et al., 2007). NF-κB activation is signiﬁcantly increased after
infection of macrophages with an SseL mutant, and this activ-
ity can be decreased to wild-type levels by complementation with
a low copy plasmid expressing SseL. These results show that the
action of SseL is to decrease NF-κB signaling, thereby decreasing
the anti-apoptotic and pro-inﬂammatory effects of this pathway.
SseL deubiquitinates IκBα, the major regulator of the classical
NF-κB activation pathway. In the NF-κB pathway, activation of
IKK leads to phosphorylation of the inhibitor IκBα, targeting the
inhibitor for ubiquitination and degradation by the proteosome.
However, the deubiquitinating activity of SseL blocks degrada-
tion of IκBα and maintains the inhibition of NF-κB, preventing
nuclear translocation and induction of NF-κB-dependent genes.
As a result of the action of SseL in the host cell, both pro-
inﬂammatory and anti-apoptotic pathways dependent on NF-κB
are inhibited, allowing the pro-apoptotic effects through TRIF and
PKR (see Figure 2) to dominate. Therefore, these results provide
a mechanistic explanation for the cytotoxic effect of SseL pre-
viously reported (Rytkonen et al., 2007). The production of the
pro-inﬂammatory cytokines TNF and IL-12 are decreased during
infection of mice with wild-type serovar Typhimurium compared
to the SseL mutant. These results support the idea that SseL may
also act in concert with other effectors to decrease activation of
innate immunity.
PROPOSED MODEL FOR THE VIRULENCE EFFECTS OF SpvB
AND SpvC IN SALMONELLA INFECTION
Early in the analysis of the spv genes, genetic studies indicated
that both SpvB and SpvC are required for the virulence phe-
notype encoded by the spv region (Roudier et al., 1992). A
model to account for this ﬁnding is proposed in Figure 3. In
this model, SpvB and SpvC act by different biochemical mech-
anisms, but they affect the same cellular pathways involved in
the pathogenesis of intracellular Salmonella infection. Both SpvB
and SpvC are translocated into the host cell cytoplasm by the
SPI-2 TTSS (Browne et al., 2008; Mazurkiewicz et al., 2008).
Actin depolymerization and induction of apoptosis are major
effects of SpvB during intracellular Salmonella infection (Libby
et al., 2000; Lesnick et al., 2001; Browne et al., 2002). Recent
studies have shown that the NADPH oxidase associates with
actin ﬁlaments during the organization and assembly of the oxi-
dase on the membrane (elBenna et al., 1994; Allen et al., 1999;
Zhan et al., 2004; Tamura et al., 2006), and wild-type Salmo-
nella decreases NADPH oxidase recruitment to the phagosome
by an SPI-2-dependent mechanism (Vazquez-Torres et al., 2000;
Gallois et al., 2001). Therefore, SpvB-mediated actin depolymer-
ization may decrease oxidase assembly and recruitment to the
phagosome, and therefore could decrease oxidative killing of
Salmonella. The second effect of SpvB-mediated actin depoly-
merization is to induce apoptosis (Libby et al., 2000; Lesnick
et al., 2001). The phosphothreonine lyase activity of SpvC acts
to decrease MAP kinase signaling, and inhibition of p38 has
been demonstrated. As proposed in Figure 3, SpvC inhibition
of the p38 MAP kinase isoform would block the synthesis of
anti-apoptotic factors and therefore trigger apoptosis, in concert
with the effects of SpvB. Macrophage apoptosis is one poten-
tial common pathway for the actions of SpvB and SpvC. In
addition, SpvC may block the pro-inﬂammatory signaling func-
tion of the MAP kinase isoforms, leading to lower levels of key
macrophage-activating cytokines such as TNF. Salmonella infec-
tions are known tobemore severe inTNF-deﬁcientmice (Vazquez-
Torres et al., 2001). TNF has been shown promote localization
of the NADPH oxidase to the phagosome of Salmonella-infected
macrophages (Vazquez-Torres et al., 2001). Furthermore, theMAP
kinase p38 has a direct effect in promoting oxidase assembly
through phosphorylation of the p47 phox subunit (Laroux et al.,
2005). Therefore, SpvC could act in concert with SpvB to block
the recruitment of a functional NADPH oxidase to the phago-
some. The SpvB and SpvC effects may be enhanced by the chro-
mosomal sseL gene product, which further promotes apoptosis
and decreases macrophage activation through blockade of NF-κB
activity.
The virulence effect of decreasing NADPH oxidase activity
is readily apparent, and infections in phox knockout mice have
shown that oxidative killing is a major host defense mechanism
against Salmonella (Mastroeni et al., 2000). The virulence effect of
inducing apoptosis in infected macrophages has not been estab-
lished.Host cell apoptosis has beendescribedwithmany infectious
agents (Guiney,2005). In some systems,pathogenvirulence factors
appear to inhibit apoptosis, while in other systems, key virulence
factors promote apoptosis. For Salmonella, we propose that induc-
tion of macrophage apoptosis late in the intracellular infection
cycle is a speciﬁc virulence mechanism that facilitates cell-to-cell
spread of the bacteria (Guiney, 2005). Apoptosis induces cell sur-
face changes that stimulate receptor-mediated uptake of apoptotic
cells by surrounding macrophages, thereby transferring infection
to these naïve macrophages. Therefore, the induction of apoptosis
by Salmonella may represent a speciﬁcmechanismpromoting cell-
to-cell spread and subsequent rounds of macrophage infection.
If Salmonella produced necrosis or pyroptosis during infection,
free bacteria would be released into the extracellular space. The
inability of extracellular antibiotics such as gentamicin to control
Salmonella infection is strong evidence in favor of the importance
of a cell-to-cell spread mechanism (Fierer et al., 1990). The model
proposes that this intracellular infection cycle of spv+ Salmonella
can only be terminated by the induction of speciﬁc CD4+ T cell
immunity.
The ability of Salmonella to cause sustained intracellular infec-
tion has been awell-established paradigm in pathogenesis, and this
principle has been conﬁrmed by numerous experimental studies
indicating thatCD4+Tcell immunity is required for control of the
infection (reviewed in Mittrucker andKaufmann, 2000;Mastroeni
and Menager, 2003). This concept is strongly supported by the key
clinical observation in humans that the CD4+ cell depletion seen
inHIV infection and other immune deﬁciency conditions strongly
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FIGURE 3 | Hypothetical model for the combined effects of SpvB, SpvC,
and SseL to promote Salmonella virulence. In this model, SpvB, SpvC, and
SseL could act by different biochemical mechanisms to inhibit NADPH
oxidase recruitment to the phagosome and also to promote host cell
apoptosis. The overall effect of host cell apoptosis may to be promote
cell-to-cell spread of the infection, since extracellular antibiotics such as
gentamicin, and phagocytosis of extracellular bacteria by neutrophils, are not
able to terminate infections with Salmonella strains that express spv genes.
This model would provide an explanation for the experimental and clinical
evidence that CD4T cells and IFN-gamma are required to control infections
due to spv+ Salmonella, likely involving macrophage activation and killing of
intracellular bacteria.
predisposes to persistent disseminated non-typhoid Salmonella
disease (Gilks et al., 1990; Arthur et al., 2001).
ROLE OF THE spv LOCI IN HUMAN INFECTIONS WITH
SALMONELLA
The role of the spv locus in the mouse model of salmonellosis is
well established, but its role in human infection is less appreci-
ated. S. enterica strains cause three distinct illnesses in humans.
The ﬁrst and most common disease is gastroenteritis; it is esti-
mated that more than one million cases occur annually in the
USA alone (Mead et al., 1999). The other two less common syn-
dromes are typhoid or enteric fever (Tauxe, 1997), and Salmonella
bacteremia. Of the greater than 2000 serovars of S. enterica that
are identiﬁed using the Kauffman–White typing scheme, about 20
serovars, mostly in O antigen groups B, C, D, and E (Jones et al.,
2008), cause the vast majority of cases of gastroenteritis, as these
strains are widely distributed amongst domestic food animals and
so enter the food chain (Foley and Lynne, 2008). Bacteremia rarely
accompanies gastroenteritis, and when it does, it is usually tran-
sient (Goldberg and Rubin, 1988). Of the most commonly isolated
serovars from stool cultures only Typhimurium and Enteritidis
can carry virulence plasmids that encode the spv operon, indi-
cating that spv genes are not required to cause gastroenteritis
in people.
In contrast to gastroenteritis, enteric fever is caused by two
serovars: Typhi and Paratyphi A (Goldberg and Rubin, 1988).
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These organisms are host adapted to humans and are spread fecal-
orally via contaminated food or water. Enteric fever is a sub-acute
to chronic disease characterized by a transient rash, fever, weight
loss, cough, and headache, but rarely diarrhea. Clinically, the infec-
tion localizes in the RES, as hepatosplenomegaly and abnormal
liver function tests are common. Bacteremia is present in the ﬁrst
week of the illness but is either transient or very low grade in
the following weeks. However, the organism can still be recovered
from the bone marrow, another indication of its RES localization
(Hoffman et al., 1984). Neither Typhi nor Paratyphi A possesses
spv genes. Furthermore, typhoid fever does not have an increased
incidence or altered pathogenesis in HIV patients, indicating that
CD4+ T cell immunity is not crucial for the human host response
to typhoid.
In contrast, non-typhoid Salmonella bacteremias are usually
due to strains that encode the spv locus (Guiney et al., 1995),
implying that spv products are required for bacteremia. The evi-
dence for this is indirect, since it would be unethical to try
to compare the dissemination potential of isogenic strains of
Salmonella in humans. Therefore, the evidence for this association
is obtained from molecular epidemiological studies of patients
with Salmonella bacteremia to determine if there is a relation-
ship between the clinical syndrome and infections with spv+
Salmonella. Salmonella bacteremia is distinct from enteric fever, in
most cases presenting as high fever, usually without a rash or local-
izing signs or symptoms unless it has already caused a metastatic
infection, e.g., infection of a bone or joint. Diarrhea is uncommon,
and often there is no history of recent intestinal symptoms. The
diagnosis of Salmonella bacteremia is established by positive blood
cultures for non-typhoid S. enterica. In older immunocompetent
patients S. enterica bacteremia in the absence of localizing signs or
symptoms suggests the presence of a mycotic aneurysm (Cohen
et al., 1978). With rare exceptions the aneurysms are infected with
serovars known to carry virulence plasmids (Mendelowitz et al.,
1979).
The syndrome of non-typhoid Salmonella bacteremia was ﬁrst
recognized as a manifestation of human infection with serovar
Choleraesuis, a pig-adapted pathogen. In a study of 329 culture-
proven cases of Choleraesuis in the northeastern US, only 26 had
isolated gastroenteritis, while 239 isolates were from blood, and
another 88 were from extra-intestinal sites of infection, such as
CSF and abscesses (Saphra and Winter, 1957). Since all strains
of Choleraesuis carry a virulence plasmid with the spv operon,
this establishes an association between spv genes and the extra-
intestinal infection syndrome, even though those particular iso-
lates were not tested to see if they were spv+. This study and others
(Maccready et al., 1957) showed that Choleraesuis can cause inva-
sive infections in patients with no known immunological defects.
In most developed countries S. Choleraesuis is now an uncom-
mon human isolate, probably because of improvements in animal
husbandry that have greatly reduced the risk of human infection.
The other spv bearing serovars are relatively less virulent in
humans thanCholeraesuis,mostly infecting patients with immun-
odeﬁciencies. More recently serovar Dublin has emerged as a
cause of Salmonella bacteremia (Fierer, 1983; Fang and Fierer,
1991). Like Choleraesuis, Dublin infections present primarily as
bacteremia without gastroenteritis (Fang and Fierer, 1991). Most
infections with this bovine-adapted serovar are acquired from
drinking unpasteurized milk or other dairy products (Headrick
et al., 1998). Patients with T cell immune defects are over-
represented in case series of Dublin infection (Werner et al., 1979;
Fang and Fierer, 1991), suggesting that the functions of spv genes
are largely controlled by a normal CD4 T cell response to infec-
tion. The most frequent serovars causing Salmonella bacteremia
are Typhimurium and Enteritidis. Since they are also the most
common causes of gastroenteritis one might assume that their
prominence in the former reﬂects their prominence in the latter
syndrome. However, if this was the whole explanation, one would
expect stool and blood isolates to have the same prevalence of spv
genes, but this is not the case (Fierer et al., 1992). In epidemi-
ologically unrelated isolates from different states in the United
States, 76% of the blood isolates carried spv genes, about twice
the percentage of fecal isolates. Since clinical information was not
available for these cases, it is not certain that all the blood isolates
were from patients with the syndrome of Salmonella bacteremia,
which may explain why nearly 25% of blood isolates did not have
spv genes.Heithoff et al. (2008) examined S.Typhimurium isolates
from Utah and they found that 10/10 blood isolates had the spv
locus,while only 19/29 fecal isolates had spv.Others have examined
the proportion of isolates of different serovars that cause bac-
teremia and Dublin and Choleraesuis stand out because they have
such a high ratio of blood to fecal isolates (Blaser and Feldman,
1981; Jones et al., 2008).
The AIDS epidemic revealed the importance of CD4 T cells in
preventing Salmonella bacteremia, a syndrome that was often the
presenting manifestation of AIDS (Celum et al., 1987; Gruenewald
et al., 1994). In those publications that included information about
the serovars involved, they were nearly always strains that are
known to carry virulence plasmids (Blaser and Feldman, 1981;
Celum et al., 1987; Gruenewald et al., 1994). One exception was S.
enterica serovar Arizona, an infection of patients who had AIDS
and ingested folk remedies made from rattlesnakes (Noskin and
Clarke, 1990). Subsequently, these isolates were shown to have the
spv operon inserted in the chromosome (Libby et al., 2002).
Non-typhoid Salmonella bacteremia is a very commonproblem
in sub-Saharan Africa, in both adults and children. Very few stud-
ies have looked for the presence of spv genes in the African blood
culture isolates, but one large study of S. Typhimurium blood cul-
ture isolates from Malawi and two regions of Kenya found that
all of them had virulence plasmids (Kingsley et al., 2009). Dis-
turbingly, many of the isolates carried a pSLT virulence plasmid
that had a large transposon insert encoding multiple antibiotic
resistance genes. This genetic association has also been observed
in S. Typhimurium isolates from the Asturia region of Spain,
potentially linking selection for virulence with that for antibi-
otic resistance. Recently, analysis of 24 blood culture isolates from
AIDS patients in Uganda, comprising serovars Typhimurium,
Typhimurium var Copenhagen, and Enteritidis, has found that all
contained the spvB gene (unpublished results; Fierer and Guiney).
Thus, it appears likely that the spv operon is necessary for the syn-
drome of Salmonella bacteremia in AIDS, regardless of the serovar
involved. To establish this, one would need to examine isolates for
people in the same communities with gastroenteritis and show
that a lower percentage had the virulence plasmid.
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SUMMARY
The spv genes comprise an accessory virulence locus in Salmonella
located on virulence plasmids in the subspecies I lineage and in the
chromosome of certain other subspecies. Regulation of expres-
sion of the spv operon occurs through the SpvR transcription
activator and the RpoS sigma factor, and responds physiologically
to the stationary phase of growth and the intracellular environ-
ment of host cells. SpvB and SpvC have been identiﬁed as essential
effector proteins for the spv virulence phenotype and their bio-
chemical activities have been characterized. Both SpvB and SpvC
are translocated by the TTSS encoded by SPI-2. SpvB is an ADP-
ribosyltransferase that modiﬁes G-actin and prevents polymer-
ization to F-actin, thereby disrupting the actin cytoskeleton. SpvC
has phosphothreoninelyase activity and inhibitsMAP kinases. The
mechanisms of the concerted virulence effects of SpvB and SpvC
remain to be determined. SpvB has been shown to be required
for apoptosis in human macrophages, and may act together with
SpvC and other Salmonella effectors.
Evidence from experimental models and human epidemiologic
data indicate that the spv genes promote the virulence of non-
typhoid Salmonella serovars to cause extra-intestinal disease. The
spv genes appear to subvert the innate immune mechanisms in
the host that are able to terminate the common intestinal infec-
tions due to non-typhoid Salmonella manifested as self-limited
gastroenteritis. Resistance to spv-expressing Salmonella causing
disseminated infection appears to require acquired immunity
mediated by CD4+ T cells as demonstrated experimentally in
mice and by the high incidence of spv+ non-typhoid Salmonella
bacteremia in HIV infection. Analysis of the distribution of the
spv locus in Salmonella serovars has underscored a key difference
between the pathogenesis of typhoid fever and non-typhoid Sal-
monella bacteremia in people. The typhoid serovars Typhi and
Paratyphi lack the spv genes, and are not associated with increased
infections in patients deﬁcient in CD4+ T cells. Therefore, the
mechanisms of pathogenesis and host immunity are likely to have
important differences between typhoid and non-typhoid serovars
of Salmonella.
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